NEOseq_ACTION
Commercial- Indications
- Rare genetic diseases
Company intelligence / Profile preview
MedySapiens
Seoul, Seoul, South Koreamedysapiens.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
MedySapiens has developed an AI-driven genomics platform that enables rapid diagnosis of over 220 actionable rare diseases using a small blood sample from newborns. Clinical validation has been completed retrospectively and prospectively at leading hospitals such as Seoul National University Hospital. The technology is being piloted internationally to secure multiethnic genomic data sets for improved precision medicine applications
- Therapeutic areas
- PsychiatryEndocrinologyRare DiseasesNeurology
- Modalities
- Next Generation Sequencing (NGS)Bioinformatics software solutionGenetic panel diagnostics
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Sharp Healthcare Group / Sharp Mary Birch Hospital for Women & Newborns (USA)Seoul National University Hospital (Korea)Massachusetts General Hospital / Harvard Medical School (USA)Taipei Medical University & BE Accelerator/BioMed Accelerator Program (Taiwan)Manila HealthTek & Justice Jose Abad Santos General Hospital/JJASGH (Philippines)
Beyond the preview
Go deeper on MedySapiens.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MedySapiens.